EUVIMEDEUVIMED entdecken
Crossref

L26/P-634 Expanding the Genetic Spectrum of Idiopathic Premature Ovarian Insufficiency through Whole Exome Sequencing in Cases with Genetic Susceptibility

M. Bazrgar, M. Sarvizadeh-Fini, A. Amiri-Yekta, M. Kazemi, E. Amiri-Amirhendeh, S. Karimi, N. Rahbarian-Yazdi, K. Ommi, K. Ahmadpour, K. Eslami, Z. Adineh, P. Borjian Boroujeni und 3 weitere

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.964 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M. Bazrgar und 14 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question How genetic susceptibility change the probability of Pathogenic/likely pathogenic (P/LP) variants identification in women with idiopathic premature ovarian insufficiency (POI)? Summary answer WES identified P/LP variants across subgroups, with the highest incidence in the cases with familial history of POI without parental consanguinity, and primary amenorrhea (PA). What is known already POI is a genetically heterogeneous disorder affecting 1–4% of women, characterized by ovarian dysfunction before age 40 that results in infertility. Although mutations in genes such as FMR1, NR5A1, POLG, and FSHR have been linked to POI, the majority of cases remain unexplained. Recent advances in next-generation sequencing (NGS), including whole-exome (WES) and whole-genome sequencing (WGS), enable the identification of novel genetic variants. These technologies improve understanding of POI’s genetic etiology and support early diagnosis and genetic counseling, particularly in patients with a family history, offering potential for personalized management strategies. Study design, size, duration Among approximately 300 medical records of women with POI, pedigree-based selection identified 39 idiopathic patients with genetic susceptibility. Twenty-three cases had familial POI, including six with and seventeen without parental consanguinity. Nine sporadic patients presented with primary amenorrhea, while seven had syndromic POI or familial reproductive disorders in relatives. All participants underwent WES for comparative genetic analysis across defined clinical subgroups within this study cohort. Participants/materials, setting, methods WES was performed on blood-derived DNA from probands, followed by both targeted and untargeted analyses to identify potentially causal variants. Candidate genes were prioritized for their roles in menstrual regulation, folliculogenesis, and ovarian function. Variant pathogenicity was interpreted under ACMG criteria. Putative deleterious variants were subsequently validated by Sanger sequencing in probands and available relatives to confirm segregation. Identified genes underwent our scoring framework that is under review Human Reproduction Update. Main results and the role of chance WES identified 31 P/LP variants in the cohort, including six novel candidate genes, along with 77 variants of uncertain significance. The incidence of P/LP variants was highest among familial POI cases without consanguinity (76%), followed by PA (57%). Classification according to amenorrhea status without consideration of the patients’ subgroups showed a higher proportion of pathogenic variants in PA (17.9%) than in secondary amenorrhea (SA) (3.6%), supporting a stronger contribution of genetic factors in PA. Segregation analysis in 13 available families showed inheritance patterns consistent with disease involvement in multiple cases. Observed patterns included homozygous variants inherited from heterozygous carrier parents, vertical transmission consistent with dominant inheritance, and co-segregation of candidate variants with affected relatives, whereas unaffected family members frequently lacked these variants. These findings provide additional evidence for the clinical relevance of several detected variants and reinforce the contribution of genetic factors in familial POI. Application of our gene-evidence scoring framework classified NR5A1 and POLG as definitive POI genes, while LARS2, BRCA2, HFM1, BMP15, and ERCC6 demonstrated strong evidence for involvement in POI. Identified genes spanned multiple biological pathways, including DNA repair, mitochondrial function, meiotic regulation, and follicular development, underscoring the complex oligogenic architecture underlying POI. Limitations, reasons for caution Interpretation is limited by incomplete segregation data, with samples unavailable for 26 families, a lack of functional validation for several variants, and the enrichment of clinically selected cases, which restricts generalizability. Variants of uncertain significance require larger cohorts and functional studies to clarify pathogenicity and improve diagnostic accuracy. Wider implications of the findings These findings expand understanding of POI genetics and highlight the value of genomic testing in care, particularly for primary amenorrhea or familial cases. Better molecular diagnosis supports clearer counseling, earlier reproductive planning, and more personalized management, while guiding future research toward improved prevention and treatment options for affected women worldwide. Trial registration number No

Zitieren

APA

Bazrgar, M., Sarvizadeh-Fini, M., Amiri-Yekta, A., Kazemi, M., Amiri-Amirhendeh, E., Karimi, S., Rahbarian-Yazdi, N., Ommi, K., Ahmadpour, K., Eslami, K., Adineh, Z., Boroujeni, P. B., Ghafari, P., Almadani, N., & Mashayekhi, M. (2026). L26/P-634 Expanding the Genetic Spectrum of Idiopathic Premature Ovarian Insufficiency through Whole Exome Sequencing in Cases with Genetic Susceptibility. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.964

Vancouver

Bazrgar M, Sarvizadeh-Fini M, Amiri-Yekta A, Kazemi M, Amiri-Amirhendeh E, Karimi S, et al. L26/P-634 Expanding the Genetic Spectrum of Idiopathic Premature Ovarian Insufficiency through Whole Exome Sequencing in Cases with Genetic Susceptibility. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.964

BibTeX
@article{Bazrgar2026,
  author = {Bazrgar, M. and Sarvizadeh-Fini, M. and Amiri-Yekta, A. and Kazemi, M. and Amiri-Amirhendeh, E. and Karimi, S. and Rahbarian-Yazdi, N. and Ommi, K. and Ahmadpour, K. and Eslami, K. and Adineh, Z. and Boroujeni, P. Borjian and Ghafari, P. and Almadani, N. and Mashayekhi, M.},
  title = {L26/P-634 Expanding the Genetic Spectrum of Idiopathic Premature Ovarian Insufficiency through Whole Exome Sequencing in Cases with Genetic Susceptibility},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.964}
}
Kostenlos starten →